DAVID BLACKSHEAR: Open Payments
NPI 1982382198 · THE WOODLANDS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 39 payments from 14 companies in 2025. Trend: 2023 $189 · 2024 $653 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $231 |
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| PFIZER INC. | 3 | $83 |
| Lilly USA, LLC | 2 | $41 |
| Seqirus USA Inc | 2 | $33 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Medtronic, Inc. | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $21 |
Products named: Wegovy, AIRSUPRA, Ozempic, NURTEC ODT, MOUNJARO, Flucelvax, VAXELIS, SYMPLICITY G3.
Industry payments across TX — which companies pay providers there.
